URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS

Manuela Livio, Donatella Marchesi, Giuseppe Remuzzi, Eliana Gotti, Giuliano Mecca, Giovanni De Gaetano

Research output: Contribution to journalArticle

244 Citations (Scopus)

Abstract

Bleeding time, altered in most uraemic patients, may be influenced by packed cell volume (PCV). Uraemic patients are often anaemic, so the influence of PCV on bleeding time was assessed in several groups of patients with chronic uraemia. The findings were that bleeding times in uraemic patients are profoundly influenced by anaemia, and that the platelet-mediated haemorrhagic tendency in uraemia may be successfully managed by raising PCV values to above 30%.

Original languageEnglish
Pages (from-to)1013-1015
Number of pages3
JournalLancet
Volume320
Issue number8306
DOIs
Publication statusPublished - Nov 6 1982

Fingerprint

Bleeding Time
Anemia
Cell Size
Hemorrhage
Uremia
Blood Platelets

ASJC Scopus subject areas

  • Medicine(all)

Cite this

URAEMIC BLEEDING : ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS. / Livio, Manuela; Marchesi, Donatella; Remuzzi, Giuseppe; Gotti, Eliana; Mecca, Giuliano; De Gaetano, Giovanni.

In: Lancet, Vol. 320, No. 8306, 06.11.1982, p. 1013-1015.

Research output: Contribution to journalArticle

Livio, Manuela ; Marchesi, Donatella ; Remuzzi, Giuseppe ; Gotti, Eliana ; Mecca, Giuliano ; De Gaetano, Giovanni. / URAEMIC BLEEDING : ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS. In: Lancet. 1982 ; Vol. 320, No. 8306. pp. 1013-1015.
@article{b27efe9972b44a3b9b92a639d45df964,
title = "URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS",
abstract = "Bleeding time, altered in most uraemic patients, may be influenced by packed cell volume (PCV). Uraemic patients are often anaemic, so the influence of PCV on bleeding time was assessed in several groups of patients with chronic uraemia. The findings were that bleeding times in uraemic patients are profoundly influenced by anaemia, and that the platelet-mediated haemorrhagic tendency in uraemia may be successfully managed by raising PCV values to above 30{\%}.",
author = "Manuela Livio and Donatella Marchesi and Giuseppe Remuzzi and Eliana Gotti and Giuliano Mecca and {De Gaetano}, Giovanni",
year = "1982",
month = "11",
day = "6",
doi = "10.1016/S0140-6736(82)90050-2",
language = "English",
volume = "320",
pages = "1013--1015",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Lancet Publishing Group",
number = "8306",

}

TY - JOUR

T1 - URAEMIC BLEEDING

T2 - ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS

AU - Livio, Manuela

AU - Marchesi, Donatella

AU - Remuzzi, Giuseppe

AU - Gotti, Eliana

AU - Mecca, Giuliano

AU - De Gaetano, Giovanni

PY - 1982/11/6

Y1 - 1982/11/6

N2 - Bleeding time, altered in most uraemic patients, may be influenced by packed cell volume (PCV). Uraemic patients are often anaemic, so the influence of PCV on bleeding time was assessed in several groups of patients with chronic uraemia. The findings were that bleeding times in uraemic patients are profoundly influenced by anaemia, and that the platelet-mediated haemorrhagic tendency in uraemia may be successfully managed by raising PCV values to above 30%.

AB - Bleeding time, altered in most uraemic patients, may be influenced by packed cell volume (PCV). Uraemic patients are often anaemic, so the influence of PCV on bleeding time was assessed in several groups of patients with chronic uraemia. The findings were that bleeding times in uraemic patients are profoundly influenced by anaemia, and that the platelet-mediated haemorrhagic tendency in uraemia may be successfully managed by raising PCV values to above 30%.

UR - http://www.scopus.com/inward/record.url?scp=0019973424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019973424&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(82)90050-2

DO - 10.1016/S0140-6736(82)90050-2

M3 - Article

C2 - 6127502

AN - SCOPUS:0019973424

VL - 320

SP - 1013

EP - 1015

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8306

ER -